The progress on the use of botulinum toxin type A therapy in Parkinson′s disease
10.3760/cma.j.cn113694-20210522-00359
- VernacularTitle:A型肉毒毒素治疗帕金森病研究进展
- Author:
Rongrong BAI
1
;
Yali TANG
;
Lazhen SHE
;
Chunyu WANG
Author Information
1. 中南大学湘雅二医院神经病学科，长沙 410011
- Keywords:
Botulinum toxin, type A;
Parkinson disease;
Therapeutic uses
- From:
Chinese Journal of Neurology
2022;55(1):70-76
- CountryChina
- Language:Chinese
-
Abstract:
Botulinum toxin type A (BTX A) has gain widespread use in various neurological conditions, characterized by safe injection and less side-effect. This review will examine the current research of BTX A in the following aspects: mechanism, location, dose and outcome, which manifests the safety and efficacy data of BTX A injection treatment to the symptoms of Parkinson disease, including refractory tremor, focal dystonia, loss of postural reflexes, sialorrhea, gastrointestinal symptoms and depressive disorder.
